Human Babies from CRISPR Pigs
By Stuart Newman,
HuffPost Science
| 02. 29. 2016
New genetic technologies like CRISPR/Cas9 gene editing and synthetic biology are leading us to entirely new definitions of disease. Now "patients" include people who want children who lack some of their own genes, or have additional ones that they themselves lack. Also among the new patients are people who in the past were too old to have children as well some women who get sick from pregnancy and childbirth, or even the idea of them. Technological advances on the horizon may eventually offer treatment for such conditions.
In February 2015 the British Parliament approved production of "three-parent" children by transferring the nucleus of one woman's egg into the nucleus-less ("enucleated") egg of a second woman to avoid the propagation of certain rare "mitochondrial" diseases, Though there were acknowledged risks of the unprecedented procedure (including the possibility of producing novel birth defects), the argument that prevailed was that some mitochondrial diseases are so devastating that it should be tried in the narrowly defined group of prospective mothers carrying defective mitochondria.
Not long afterward, news articles began to appear discussing use of...
Related Articles
Riquet Mammoth Kakao (c.1920)
by Ludwig Hohlwein, Public Domain via Flickr
Colossal, the de-extinction company, scored headlines (1, 2, 3, 4, 5) recently by announcing that they had created mice! Not just any mice, not even colossal mice, but genetically engineered, normal-size “woolly mice” that are the result of editing seven genes in mouse embryos. This Colossal presented as an important step toward making a specimen of charismatic megafauna – a...
By Ben Johnson, Nature | 02.14.2025
A London-based biotech has amassed the world’s largest ethically sourced foundational biodiversity database for training artificial intelligence (AI) by setting up partnerships with 25 countries around the world. The startup, Basecamp Research, announced in January the launch of a new...
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...